Trials / Completed
CompletedNCT03616392
Clinical Trial to Evaluate the Drug Drug Interaction of CKD-501 and D308
A Randomized, Open-label, Multiple Dose, 2-way Crossover Study to Evaluate the Drug Drug Interaction of CKD-501 and D308 in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
Phase 1 trial to evaluate the drug drug interaction of CKD-501 and D308
Detailed description
A randomized, open-label, multiple dose, 2-way crossover study to evaluate the drug drug interaction of CKD-501 and D308 in healthy volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | D308, CKD-501 | 1. D308 2. CKD-501: Lobeglitazone sulfate 0.5mg |
Timeline
- Start date
- 2018-07-25
- Primary completion
- 2018-09-17
- Completion
- 2018-11-13
- First posted
- 2018-08-06
- Last updated
- 2018-11-19
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03616392. Inclusion in this directory is not an endorsement.